Health & Environmental Research Online (HERO)


Print Feedback Export to File
6304523 
Journal Article 
Binding specificities of estrogen receptor with perfluorinated compounds: A cross species comparison 
Qiu, Z; Qu, K; Luan, F; Liu, Y; Zhu, Y; Yuan, Y; Li, H; Zhang, H; Hai, Y; Zhao, C 
2020 
Environment International
ISSN: 0160-4120
EISSN: 1873-6750 
PERGAMON-ELSEVIER SCIENCE LTD 
OXFORD 
134 
105284 
English 
BACKGROUND: Perfluorinated compounds (PFCs) were reported to result in the endocrine disruption by activating the estrogen receptor (ER) and inducing ER-mediated transcriptions.

OBJECTIVE: The aim of the present work was to perform cross-species comparisons on the characteristics of eight PFCs binding to humans ERα and to rats ERα.

METHODS: In the present work, in vivo tests, including serum estradiol level assay and immunohistochemical staining, fluorescence assay and molecular models were applied.

RESULTS: Based on the in vivo experiments, the exposure of PFOA and PFOS to female rats was proved to increase the ERα expression in the terus, suggesting that PFCs may act as estrogenic compounds to activate ERα in vivo. The further fluorescence assay presented that these eight PFCs have stronger binding abilities to human ERα than to rat ERα. In addition, the differences in binding specificities between human ERα and rat ERα were identified in the process of molecular dynamics modeling with the term of helix position and the ability of coregulator recruitment. It can be found that more and stronger charge clamps could form between PFCs with human ERα than with rat ERα. Also, the eight PFCs presented lower binding energies in human ERα systems, which proved that eight PFCs presented much stronger binding abilities with human ERα.

DISCUSSION: In all, it can be concluded that PFCs might be more sensitive to human ERα than to that of rats, which also suggested the greater susceptibility to adverse effects on humans. The present work was a beginning assessment of a cross-species comparison, providing important information on health impacts of PFCs in humans. 
Perfluorinated compounds (PFCs); Estrogen receptor (ER); Cross species comparison; Molecular dynamics 
PFAS
• Additional PFAS (formerly XAgency)
     Literature Search November 2019
          Other Sources
               Reference list review of included studies
     Screened Studies
          Excluded
               Exclude (TIAB)
• PFAS 150
     Literature Search Update December 2021
          PubMed
          WOS
     Missing 2021 searches
     Literature Search Update December 2020
          PubMed
          WOS
     Literature Search August 2019
          PubMed
          Web of Science
     Screened Studies
          Supplemental
     Perfluorinated compounds
• PFBA
     June 2022 Pelch Database
• PFBS
     Search
          WOS
     Lit Search Update: May 2019 - May 2020
          WoS
• PFHxA
     Results pulled from Pelch database May 2022
     HAWC
• PFHxS
     Database searches
          Pelch PFAS SEM
     Supplemental
          TiAb
          In vivo mechanistic or MOA studies, including non-PECO routes of exposure and populations
     Literature Search Update April 2023
          Supplemental
               In vivo mechanistic or MOA studies, including non-PECO routes of exposure (e.g., nonmammalian)
• PFOA (335-67-1) and PFOS (1763-23-1)
     LitSearch: Feb 2019 - May 2020
          PubMed
          WoS
     Literature Search Update (Apr 2019 - Sep 2020)
          PubMed
          WOS